Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs-Reference-Cited by-同舟云学术

Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs

Published:2016-05 Issue:3 Volume:90 Page:535-550
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

Jiang Jie,Zhu Qiang,Gendron Tania F.,Saberi Shahram,McAlonis-Downes Melissa,Seelman Amanda,Stauffer Jennifer E.,Jafar-nejad Paymaan,Drenner Kevin,Schulte Derek,Chun Seung,Sun Shuying,Ling Shuo-Chien,Myers Brian,Engelhardt Jeffery,Katz Melanie,Baughn Michael,Platoshyn Oleksandr,Marsala Martin,Watt Andy,Heyser Charles J.,Ard M. Colin,De Muynck Louis,Daughrity Lillian M.,Swing Deborah A.,Tessarollo Lino,Jung Chris J.,Delpoux Arnaud,Utzschneider Daniel T.,Hedrick Stephen M.,de Jong Pieter J.,Edbauer Dieter,Van Damme Philip,Petrucelli Leonard,Shaw Christopher E.,Bennett C. Frank,Da Cruz Sandrine,Ravits John,Rigo Frank,Cleveland Don W.,Lagier-Tourenne Clotilde

Publisher

Elsevier BV

Subject

General Neuroscience

Reference68 articles.

1. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS;Ash;Neuron,2013

2. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice;Atanasio;Sci. Rep.,2016

3. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood;Belzil;Acta Neuropathol.,2013

4. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD;Boeynaems;Sci. Rep.,2016

5. Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits;Chew;Science,2015

Cited by 443 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study;The Lancet Neurology;2024-09

2. Identification of selective and non-selective C9ORF72 targeting in vivo active siRNAs;Molecular Therapy - Nucleic Acids;2024-09

3. A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in a AAV-C9ORF72 (G₄C₂)₆₆mouse model;2024-08-27

4. Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update;Expert Opinion on Drug Discovery;2024-08-08

5. Diagnostic elements in amyotrophic lateral sclerosis: A case report;Biomedical Reports;2024-08-01